4-[[3-amino-1-(dimethylsulfamoyl)azetidin-3-yl]methylamino]-N'-(3-bromo-4-fluorophenyl)-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-fluoroazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-hydroxyazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[3-fluoro-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-[[3-methyl-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-1,2,5-oxadiazole-3-carboximidamide

C78H100Br5F7N36O21S5 — CID 160870914

IUPAC4-[[3-amino-1-(dimethylsulfamoyl)azetidin-3-yl]methylamino]-N'-(3-bromo-4-fluorophenyl)-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-fluoroazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-hydroxyazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[3-fluoro-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-[[3-methyl-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-1,2,5-oxadiazole-3-carboximidamide
SMILESCC(C)NS(=O)(=O)N1CC(C)(CNc2nonc2/C(=N/c2ccc(F)c(Br)c2)NO)C1.CC(C)NS(=O)(=O)N1CC(F)(CNc2nonc2/C(=N/c2ccc(F)c(Br)c2)NO)C1.CN(C)S(=O)(=O)N1CC(F)(CNc2nonc2/C(=N/c2ccc(F)c(Br)c2)NO)C1.CN(C)S(=O)(=O)N1CC(N)(CNc2nonc2/C(=N/c2ccc(F)c(Br)c2)NO)C1.CN(C)S(=O)(=O)N1CC(O)(CNc2nonc2/C(=N/c2ccc(F)c(Br)c2)NO)C1
InChIInChI=1S/C17H23BrFN7O4S.C16H20BrF2N7O4S.C15H18BrF2N7O4S.C15H20BrFN8O4S.C15H19BrFN7O5S/c1-10(2)25-31(28,29)26-8-17(3,9-26)7-20-15-14(23-30-24-15)16(22-27)21-11-4-5-13(19)12(18)6-11;1-9(2)25-31(28,29)26-7-16(19,8-26)6-20-14-13(23-30-24-14)15(22-27)21-10-3-4-12(18)11(17)5-10;2*1-24(2)30(27,28)25-7-15(18,8-25)6-19-13-12(22-29-23-13)14(21-26)20-9-3-4-11(17)10(16)5-9;1-23(2)30(27,28)24-7-15(25,8-24)6-18-13-12(21-29-22-13)14(20-26)19-9-3-4-11(17)10(16)5-9/h4-6,10,25,27H,7-9H2,1-3H3,(H,20,24)(H,21,22);3-5,9,25,27H,6-8H2,1-2H3,(H,20,24)(H,21,22);3-5,26H,6-8H2,1-2H3,(H,19,23)(H,20,21);3-5,26H,6-8,18H2,1-2H3,(H,19,23)(H,20,21);3-5,25-26H,6-8H2,1-2H3,(H,18,22)(H,19,20)
InChIKeySLSXYKGPALTRLP-UHFFFAOYSA-N
MW2570.73 g/mol
LogP5.54
Rot. Bonds37

About 4-[[3-amino-1-(dimethylsulfamoyl)azetidin-3-yl]methylamino]-N'-(3-bromo-4-fluorophenyl)-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-fluoroazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-hydroxyazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[3-fluoro-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-[[3-methyl-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-1,2,5-oxadiazole-3-carboximidamide

4-[[3-amino-1-(dimethylsulfamoyl)azetidin-3-yl]methylamino]-N'-(3-bromo-4-fluorophenyl)-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-fluoroazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-hydroxyazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[3-fluoro-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-[[3-methyl-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-1,2,5-oxadiazole-3-carboximidamide (PubChem CID 160870914) has the molecular formula C78H100Br5F7N36O21S5 and a molecular weight of 2570.73 g/mol. Its IUPAC name is 4-[[3-amino-1-(dimethylsulfamoyl)azetidin-3-yl]methylamino]-N'-(3-bromo-4-fluorophenyl)-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-fluoroazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-hydroxyazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[3-fluoro-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-[[3-methyl-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-1,2,5-oxadiazole-3-carboximidamide.

Molecular Properties

Compound Name4-[[3-amino-1-(dimethylsulfamoyl)azetidin-3-yl]methylamino]-N'-(3-bromo-4-fluorophenyl)-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-fluoroazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-hydroxyazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[3-fluoro-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-[[3-methyl-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-1,2,5-oxadiazole-3-carboximidamide
PubChem CID160870914
Molecular FormulaC78H100Br5F7N36O21S5
Molecular Weight2570.73 g/mol
Exact Mass2564.23
IUPAC Name4-[[3-amino-1-(dimethylsulfamoyl)azetidin-3-yl]methylamino]-N'-(3-bromo-4-fluorophenyl)-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-fluoroazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-hydroxyazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[3-fluoro-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-[[3-methyl-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-1,2,5-oxadiazole-3-carboximidamide
SMILESCC(C)NS(=O)(=O)N1CC(C)(CNc2nonc2/C(=N/c2ccc(F)c(Br)c2)NO)C1.CC(C)NS(=O)(=O)N1CC(F)(CNc2nonc2/C(=N/c2ccc(F)c(Br)c2)NO)C1.CN(C)S(=O)(=O)N1CC(F)(CNc2nonc2/C(=N/c2ccc(F)c(Br)c2)NO)C1.CN(C)S(=O)(=O)N1CC(N)(CNc2nonc2/C(=N/c2ccc(F)c(Br)c2)NO)C1.CN(C)S(=O)(=O)N1CC(O)(CNc2nonc2/C(=N/c2ccc(F)c(Br)c2)NO)C1
InChIInChI=1S/C17H23BrFN7O4S.C16H20BrF2N7O4S.C15H18BrF2N7O4S.C15H20BrFN8O4S.C15H19BrFN7O5S/c1-10(2)25-31(28,29)26-8-17(3,9-26)7-20-15-14(23-30-24-15)16(22-27)21-11-4-5-13(19)12(18)6-11;1-9(2)25-31(28,29)26-7-16(19,8-26)6-20-14-13(23-30-24-14)15(22-27)21-10-3-4-12(18)11(17)5-10;2*1-24(2)30(27,28)25-7-15(18,8-25)6-19-13-12(22-29-23-13)14(21-26)20-9-3-4-11(17)10(16)5-9;1-23(2)30(27,28)24-7-15(25,8-24)6-18-13-12(21-29-22-13)14(20-26)19-9-3-4-11(17)10(16)5-9/h4-6,10,25,27H,7-9H2,1-3H3,(H,20,24)(H,21,22);3-5,9,25,27H,6-8H2,1-2H3,(H,20,24)(H,21,22);3-5,26H,6-8H2,1-2H3,(H,19,23)(H,20,21);3-5,26H,6-8,18H2,1-2H3,(H,19,23)(H,20,21);3-5,25-26H,6-8H2,1-2H3,(H,18,22)(H,19,20)
InChIKeySLSXYKGPALTRLP-UHFFFAOYSA-N
XLogP5.54
TPSA744.78 Ų
H-Bond Donors19
H-Bond Acceptors42
Rotatable Bonds37
Heavy Atoms152
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002570.73
LogP ≤ 55.54
H-Bond Donors ≤ 519
H-Bond Acceptors ≤ 1042

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 4-[[3-amino-1-(dimethylsulfamoyl)azetidin-3-yl]methylamino]-N'-(3-bromo-4-fluorophenyl)-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-fluoroazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-hydroxyazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[3-fluoro-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-[[3-methyl-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-1,2,5-oxadiazole-3-carboximidamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[[3-amino-1-(dimethylsulfamoyl)azetidin-3-yl]methylamino]-N'-(3-bromo-4-fluorophenyl)-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-fluoroazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-hydroxyazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[3-fluoro-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-[[3-methyl-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-1,2,5-oxadiazole-3-carboximidamide?
The IUPAC name of 4-[[3-amino-1-(dimethylsulfamoyl)azetidin-3-yl]methylamino]-N'-(3-bromo-4-fluorophenyl)-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-fluoroazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-hydroxyazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[3-fluoro-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-[[3-methyl-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-1,2,5-oxadiazole-3-carboximidamide (CID 160870914) is 4-[[3-amino-1-(dimethylsulfamoyl)azetidin-3-yl]methylamino]-N'-(3-bromo-4-fluorophenyl)-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-fluoroazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-hydroxyazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[3-fluoro-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-[[3-methyl-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-1,2,5-oxadiazole-3-carboximidamide.
What is the SMILES notation for 4-[[3-amino-1-(dimethylsulfamoyl)azetidin-3-yl]methylamino]-N'-(3-bromo-4-fluorophenyl)-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-fluoroazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-hydroxyazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[3-fluoro-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-[[3-methyl-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-1,2,5-oxadiazole-3-carboximidamide?
The canonical SMILES for 4-[[3-amino-1-(dimethylsulfamoyl)azetidin-3-yl]methylamino]-N'-(3-bromo-4-fluorophenyl)-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-fluoroazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-hydroxyazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[3-fluoro-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-[[3-methyl-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-1,2,5-oxadiazole-3-carboximidamide is CC(C)NS(=O)(=O)N1CC(C)(CNc2nonc2/C(=N/c2ccc(F)c(Br)c2)NO)C1.CC(C)NS(=O)(=O)N1CC(F)(CNc2nonc2/C(=N/c2ccc(F)c(Br)c2)NO)C1.CN(C)S(=O)(=O)N1CC(F)(CNc2nonc2/C(=N/c2ccc(F)c(Br)c2)NO)C1.CN(C)S(=O)(=O)N1CC(N)(CNc2nonc2/C(=N/c2ccc(F)c(Br)c2)NO)C1.CN(C)S(=O)(=O)N1CC(O)(CNc2nonc2/C(=N/c2ccc(F)c(Br)c2)NO)C1.
What is the InChIKey of 4-[[3-amino-1-(dimethylsulfamoyl)azetidin-3-yl]methylamino]-N'-(3-bromo-4-fluorophenyl)-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-fluoroazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-hydroxyazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[3-fluoro-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-[[3-methyl-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-1,2,5-oxadiazole-3-carboximidamide?
The InChIKey is SLSXYKGPALTRLP-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H23BrFN7O4S.C16H20BrF2N7O4S.C15H18BrF2N7O4S.C15H20BrFN8O4S.C15H19BrFN7O5S/c1-10(2)25-31(28,29)26-8-17(3,9-26)7-20-15-14(23-30-24-15)16(22-27)21-11-4-5-13(19)12(18)6-11;1-9(2)25-31(28,29)26-7-16(19,8-26)6-20-14-13(23-30-24-14)15(22-27)21-10-3-4-12(18)11(17)5-10;2*1-24(2)30(27,28)25-7-15(18,8-25)6-19-13-12(22-29-23-13)14(21-26)20-9-3-4-11(17)10(16)5-9;1-23(2)30(27,28)24-7-15(25,8-24)6-18-13-12(21-29-22-13)14(20-26)19-9-3-4-11(17)10(16)5-9/h4-6,10,25,27H,7-9H2,1-3H3,(H,20,24)(H,21,22);3-5,9,25,27H,6-8H2,1-2H3,(H,20,24)(H,21,22);3-5,26H,6-8H2,1-2H3,(H,19,23)(H,20,21);3-5,26H,6-8,18H2,1-2H3,(H,19,23)(H,20,21);3-5,25-26H,6-8H2,1-2H3,(H,18,22)(H,19,20).
What are the key properties of 4-[[3-amino-1-(dimethylsulfamoyl)azetidin-3-yl]methylamino]-N'-(3-bromo-4-fluorophenyl)-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-fluoroazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-hydroxyazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[3-fluoro-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-[[3-methyl-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-1,2,5-oxadiazole-3-carboximidamide?
4-[[3-amino-1-(dimethylsulfamoyl)azetidin-3-yl]methylamino]-N'-(3-bromo-4-fluorophenyl)-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-fluoroazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-hydroxyazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[3-fluoro-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-[[3-methyl-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-1,2,5-oxadiazole-3-carboximidamide has a molecular weight of 2570.73 g/mol, XLogP of 5.54, 37 rotatable bonds, 19 hydrogen bond donors, and 42 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[3-amino-1-(dimethylsulfamoyl)azetidin-3-yl]methylamino]-N'-(3-bromo-4-fluorophenyl)-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-fluoroazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[1-(dimethylsulfamoyl)-3-hydroxyazetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-4-[[3-fluoro-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-[[3-methyl-1-(propan-2-ylsulfamoyl)azetidin-3-yl]methylamino]-1,2,5-oxadiazole-3-carboximidamide is sourced from PubChem (CID 160870914), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).